Catalyst Wire Dossier Catalyst Wire Dossier

K40 topical formulation A

· Moberg Pharma AB
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for K40 topical formulation A, covering 2010-06-04 to 2010-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Two Topical K40 Formulations in Adults With Seborrhoeic Dermatitis (SD) of the Scalp [Phase 2, Phase 3]

See pricing